Related Experiment Videos

[Changes in the adhesion between enterocytes in short-term exposures to blastomogens, retinol acetate and

Voprosy Onkologii
|January 1, 1992
PubMed

Insights

Anticarcinogens like retinol acetate and indomethacin increase cell loss in the large bowel, offering protection against intestinal carcinogens. These agents are most effective during the promotion phase of carcinogenesis.

Area of Science:

  • Gastroenterology
  • Oncology
  • Cell Biology

Background:

  • Intestinal carcinogens induce significant changes in colonic epithelial cell dynamics.
  • Understanding the role of cell loss in carcinogenesis is crucial for developing preventative strategies.

Purpose of the Study:

  • To investigate the impact of specific carcinogens and anticarcinogens on large bowel epithelial cell loss in mice.
  • To evaluate the protective effects of retinol acetate and indomethacin against chemically induced colorectal cancer.

Main Methods:

  • Administration of intestinal carcinogens (N-methyl-N-nitrosourea, 1.2-dimethylhydrazine) to mice.
  • Treatment with anticarcinogens (retinol acetate, indomethacin) under normal and carcinogen-exposed conditions.
  • Assessment of enterocyte loss rates in the large bowel epithelium of different mouse strains (Balb/c, AKR/J).

Main Results:

  • Carcinogens decreased enterocyte loss, while retinol acetate and indomethacin enhanced it.
  • Anticarcinogen treatment showed a protective effect, more pronounced against N-methyl-N-nitrosourea than 1.2-dimethylhydrazine.
  • The effects were more significant in Balb/c mice, and a correlation between protective and anticarcinogenic effects was observed.

Conclusions:

  • Retinol acetate and indomethacin enhance colonic epithelial cell loss, counteracting carcinogen-induced effects.
  • These agents appear to revert early epithelial responses to carcinogens.
  • Their efficacy suggests optimal application during the promotion phase of carcinogenesis.

Related Concept Videos